PT916347E - Solucoes farmaceuticas injectaveis contendo paracetamol e combinacoes de paracetamol com outras substancias activas - Google Patents

Solucoes farmaceuticas injectaveis contendo paracetamol e combinacoes de paracetamol com outras substancias activas

Info

Publication number
PT916347E
PT916347E PT97600009T PT97600009T PT916347E PT 916347 E PT916347 E PT 916347E PT 97600009 T PT97600009 T PT 97600009T PT 97600009 T PT97600009 T PT 97600009T PT 916347 E PT916347 E PT 916347E
Authority
PT
Portugal
Prior art keywords
paracetamol
combinations
active substances
solutions containing
injectable pharmaceutical
Prior art date
Application number
PT97600009T
Other languages
English (en)
Portuguese (pt)
Inventor
Ioulia K Tseti
Original Assignee
Uni Pharma Kleon Tsetis A B E
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8230107&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT916347(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Uni Pharma Kleon Tsetis A B E filed Critical Uni Pharma Kleon Tsetis A B E
Publication of PT916347E publication Critical patent/PT916347E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PT97600009T 1997-11-18 1997-11-18 Solucoes farmaceuticas injectaveis contendo paracetamol e combinacoes de paracetamol com outras substancias activas PT916347E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97600009A EP0916347B1 (en) 1997-11-18 1997-11-18 Pharmaceutical injectable solutions containing paracetamol and combinations of paracetamol with other active substances

Publications (1)

Publication Number Publication Date
PT916347E true PT916347E (pt) 2003-07-31

Family

ID=8230107

Family Applications (2)

Application Number Title Priority Date Filing Date
PT97600009T PT916347E (pt) 1997-11-18 1997-11-18 Solucoes farmaceuticas injectaveis contendo paracetamol e combinacoes de paracetamol com outras substancias activas
PT02023125T PT1285667E (pt) 1997-11-18 1997-11-18 Solução farmacêutica injectável de paracetamol e combinações de paracetamol com outras substâncias activas

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT02023125T PT1285667E (pt) 1997-11-18 1997-11-18 Solução farmacêutica injectável de paracetamol e combinações de paracetamol com outras substâncias activas

Country Status (8)

Country Link
EP (2) EP1285667B1 (da)
AT (2) ATE232741T1 (da)
CY (1) CY2562B1 (da)
DE (2) DE69736140T2 (da)
DK (2) DK0916347T3 (da)
ES (2) ES2265470T3 (da)
PT (2) PT916347E (da)
SI (2) SI1285667T1 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1003969B (el) * 2001-02-05 2002-08-14 U��-Pharma ����� ������ ������������ ���������� ���� Σταθερα φαρμακευτικα διαλυματα νιμεσουλιδης.
DE10112325A1 (de) * 2001-03-13 2002-10-02 Fresenius Kabi De Gmbh Lagerstabile Fertiginfusionslösungen des Paracetamols
CN1582170B (zh) * 2001-12-18 2010-05-05 联合制药克伦茨蒂斯药物实验室公司 扑热息痛的肠胃外组合物
FR2851164B1 (fr) * 2003-02-14 2005-04-22 Xuan Tho Nguyen Formulation liquide injectable de paracetamol
DE102005037653A1 (de) 2005-08-05 2007-02-15 Theraselect Gmbh Stabile, flüssige Formulierung von Paracetamol
WO2008009756A1 (es) 2006-07-18 2008-01-24 Genfarma Laboratorio S.L. Formulación líquida inyectable de paracetamol
US20110015273A1 (en) * 2008-01-17 2011-01-20 Rajnarayana Kandhagatla Stable pharmaceutical aqueous compositions
EP2243477A1 (de) 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracetamol zur parenteralen Verabreichung
US8404748B2 (en) 2009-08-13 2013-03-26 Neogen N.V. Storage-stable formulation of paracetamol in aqueous solution
EP2464332B2 (en) 2009-08-13 2025-10-15 Neogen N.V. Method for producing a storage-stable formulation of paracetamol in aqueous solution
WO2012001494A2 (en) 2010-06-30 2012-01-05 Troikaa Pharmaceuticals Limited Pharmaceutical compositions comprising paracetamol and process for preparing the same
JO3400B1 (ar) 2010-09-30 2019-10-20 Ferring Bv مركب صيدلاني من كاربيتوسين
AU2011359032A1 (en) 2011-02-10 2013-08-29 Neogen N.V. Storage-stable formulation of paracetamol in aqueous solution
CN105853348B (zh) 2011-03-10 2019-08-30 Xeris药物公司 肠胃外注射用稳定溶液
ES2574761T3 (es) 2011-10-31 2016-06-21 Xeris Pharmaceuticals, Inc. Formulaciones para el tratamiento de la diabetes
US9125805B2 (en) 2012-06-27 2015-09-08 Xeris Pharmaceuticals, Inc. Stable formulations for parenteral injection of small molecule drugs
US9018162B2 (en) 2013-02-06 2015-04-28 Xeris Pharmaceuticals, Inc. Methods for rapidly treating severe hypoglycemia
AU2015300944B2 (en) 2014-08-06 2019-07-11 Xeris Pharmaceuticals, Inc. Syringes, kits, and methods for intracutaneous and/or subcutaneous injection of pastes
US9649364B2 (en) 2015-09-25 2017-05-16 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic formulations in aprotic polar solvents
US11590205B2 (en) 2015-09-25 2023-02-28 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
BR112019024987A2 (pt) 2017-06-02 2020-06-16 Xeris Pharmaceuticals, Inc. Formulações de fármaco de molécula pequena resistente à precipitação
GB201811858D0 (en) * 2018-07-20 2018-09-05 Wockhardt Uk Ltd Liquid pharmaceutical composition for oral administration comprising paracetamol and codeine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3111591A1 (de) * 1981-03-24 1982-10-14 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Blutdrucksenkendes arzneimittel
US5296241A (en) * 1991-04-03 1994-03-22 Brimberg Barnett J Therapeutic composition and method of using same for treatment of hangover
GR1001523B (el) * 1991-07-04 1994-01-28 Uni Pharma Tsetis Kleon Farmak Ενέσιμα διαλύματα του συνδυασμού παρακεταμόλης και κωδεϊνης.
NZ248486A (en) * 1993-08-24 1996-07-26 Ashmont Holdings Limited Subst Stable anthelmintic formulation containing closantel and one or more avermectins or milbemycins in a glycol based solvent
GR1002731B (el) * 1996-10-21 1997-07-04 Uni-Pharma ����� ������ �.�.�.�. ������������ ���������� Φαρμακευτικα ενεσιμα διαλυματα περιεχοντα συνδυασμους παρακεταμολης με αλλες δραστικες ουσιες.

Also Published As

Publication number Publication date
SI0916347T1 (en) 2003-06-30
ATE329621T1 (de) 2006-07-15
EP1285667A3 (en) 2003-03-26
SI1285667T1 (sl) 2006-10-31
ES2192256T3 (es) 2003-10-01
ATE232741T1 (de) 2003-03-15
DK0916347T3 (da) 2003-04-22
DE69719189D1 (de) 2003-03-27
HK1020866A1 (en) 2000-05-26
EP1285667A2 (en) 2003-02-26
PT1285667E (pt) 2006-11-30
DK1285667T3 (da) 2006-09-11
DE69736140T2 (de) 2007-04-19
EP1285667B1 (en) 2006-06-14
EP0916347B1 (en) 2003-02-19
DE69719189T2 (de) 2003-11-27
CY2562B1 (en) 2008-07-02
ES2265470T3 (es) 2007-02-16
DE69736140D1 (de) 2006-07-27
EP0916347A1 (en) 1999-05-19

Similar Documents

Publication Publication Date Title
SI0916347T1 (en) Pharmaceutical injectable solutions containing paracetamol and combinations of paracetamol with other active substances
AR011846A1 (es) Una composicion farmaceutica, y el procedimiento para prepararla
DK0723437T3 (da) Farmaceutisk flerenhedspræparat indeholdende protonpumpeinhibitor
AR005281A1 (es) Composicion farceutica oral , procedimientos para su manufactura y uso de esa composicion farmaceutica para la preparacion de medicamentos. .
ES2192234T3 (es) Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos.
ATE345757T1 (de) Verabreichung eines arzneistoffs mittels einer sich-phasenumwandelnden formulierung
ES2160712T3 (es) Nueva preparacion farmaceutica para tratamiento del dolor.
ES2094694B1 (es) Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
ES2072447T3 (es) Locion analgesica externa y procedimiento de preparacion.
BR0014818A (pt) Imidazo-3-il-aminas bicìclicas procedimento de preparação e medicamentos que contém como substância ativa pelo menos uma imidazo-3-il-amina bicìclica
ATE401869T1 (de) Pharmazeutische zubereitungen zur externen anwendung, die nicht steroidale antiinflammatorische und analgetische wirkstoffe enthalten
IT1270594B (it) Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
YU46012B (sh) Postupak za izradu vodenih gelirajućih rastvora derivata arilpropionske kiseline koji mogu da se resporbuju kroz kožu
ATE96329T1 (de) Topisch anwendbare pharmazeutische zubereitung.
ES2130152T3 (es) Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
DE3778770D1 (de) Neue diphenylpropylamin-derivate, ihre herstellung sowie ihre pharmazeutische verwendung.
ITMI913170A1 (it) Composizione farmaceutica per uso oftalmico contenente un antiinfiammatorio non steroideo ed un decongestionante come principi attivi
NO991731D0 (no) Lokalanestetikum for utvortes bruk
ES2109131B1 (es) Composicion farmaceutica que tiene actividad analgesica.
ES2031462T3 (es) Procedimiento para producir 1-b-d-arabinofuranosilcitosina-5'-estearilfosfato monosodico y monohidrato de la misma, y compuesto farmaceutico que contiene esta ultima.
ATE258046T1 (de) Pharmazeutische, metamizol enthaltende brauseformulierung
CO4370014A1 (es) Soluciones inyectables estables de diritromicina
HUP9802005A2 (hu) Nátrium/hidrogén-csere inhibitorok alkalmazása különböző anyagok által a szívre gyakorolt nem kívánt hatások csökkentésére alkalmas gyógyszerkészítmények előállítására
DE69716485D1 (de) Taxol enthaltende pharmazeutische injektionslösung
ES2043093T3 (es) Composicion para uso cosmetico o farmaceutico.